Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SILVER SPRING, Md., April 17, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the
The FDA approved Omisirge, an allogeneic cell therapy from Gamida Cell that could improve access to stem cell transplants as treatments for blood cancers. The biotech makes its therapy from umbilical cord blood.
Gamida Cell's Omisirge shortens treatment times and reduces risk in stem cell transplant therapies.
The US Food and Drug Administration (FDA) has approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for blood cancer patients.
Ireland's foreign trade surplus increased notably in February as exports grew sharply amid a fall in imports, figures from the Central Statistics Office showed on Tuesday.